These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1480801)

  • 1. Cancer risk assessment with intermittent exposure.
    Murdoch DJ; Krewski D; Wargo J
    Risk Anal; 1992 Dec; 12(4):569-77. PubMed ID: 1480801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens.
    Felter SP; Conolly RB; Bercu JP; Bolger PM; Boobis AR; Bos PM; Carthew P; Doerrer NG; Goodman JI; Harrouk WA; Kirkland DJ; Lau SS; Llewellyn GC; Preston RJ; Schoeny R; Schnatter AR; Tritscher A; van Velsen F; Williams GM
    Crit Rev Toxicol; 2011 Jul; 41(6):507-44. PubMed ID: 21591905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using average lifetime dose rate for intermittent exposures to carcinogens.
    Kodell RL; Gaylor DW; Chen JJ
    Risk Anal; 1987 Sep; 7(3):339-45. PubMed ID: 3685541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenic risk assessment with time-dependent exposure patterns.
    Murdoch DJ; Krewski D
    Risk Anal; 1988 Dec; 8(4):521-30. PubMed ID: 3244859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluating cancer risk estimates for short-term exposure scenarios.
    Halmes NC; Roberts SM; Tolson JK; Portier CJ
    Toxicol Sci; 2000 Nov; 58(1):32-42. PubMed ID: 11053538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing cancer risks from short-term exposures in children.
    Ginsberg GL
    Risk Anal; 2003 Feb; 23(1):19-34. PubMed ID: 12635720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A risk assessment for acrylonitrile in consumer products.
    Johnston PK; Rock AR
    Sci Total Environ; 1990 Dec; 99(3):263-77; discussion 277-9. PubMed ID: 2077659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pesticide residues in food: investigation of disparities in cancer risk estimates.
    Swirsky Gold L; Stern BR; Slone TH; Brown JP; Manley NB; Ames BN
    Cancer Lett; 1997 Aug; 117(2):195-207. PubMed ID: 9377547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experiment.
    Finkelstein DM
    Biometrics; 1991 Jun; 47(2):669-80. PubMed ID: 1912266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues in biochemical applications to risk assessment: how do we evaluate individual components of multistage models?
    Anderson MW
    Environ Health Perspect; 1987 Dec; 76():175-9. PubMed ID: 3447895
    [No Abstract]   [Full Text] [Related]  

  • 12. Using the biological two-stage model to assess risk from short-term exposures.
    Chen JJ; Kodell RL; Gaylor DW
    Risk Anal; 1988 Jun; 8(2):223-30. PubMed ID: 3413310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapolation of carcinogenicity between species: qualitative and quantitative factors.
    Gold LS; Manley NB; Ames BN
    Risk Anal; 1992 Dec; 12(4):579-88. PubMed ID: 1480802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental design constraints on carcinogenic potency estimates.
    Rieth JP; Starr TB
    J Toxicol Environ Health; 1989; 27(3):287-96. PubMed ID: 2754755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How well can in vitro data predict in vivo effects of chemicals? Rodent carcinogenicity as a case study.
    Anthony Tony Cox L; Popken DA; Kaplan AM; Plunkett LM; Becker RA
    Regul Toxicol Pharmacol; 2016 Jun; 77():54-64. PubMed ID: 26879462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rodent carcinogens: setting priorities.
    Gold LS; Slone TH; Stern BR; Manley NB; Ames BN
    Science; 1992 Oct; 258(5080):261-5. PubMed ID: 1411524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services
    Natl Toxicol Program Tech Rep Ser; 2002 May; (504):1-357. PubMed ID: 12087420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating cell proliferation in quantitative cancer risk assessment: approaches, issues, and uncertainties.
    Chen C; Farland W
    Prog Clin Biol Res; 1991; 369():481-99. PubMed ID: 1946541
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship between carcinogenic potency and maximum tolerated dose is similar for mutagens and nonmutagens.
    Goodman G; Shlyakhter A; Wilson R
    Prog Clin Biol Res; 1991; 369():501-16. PubMed ID: 1946542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.